Infectious Diseases

Eur Rev Med Pharmacol Sci 2022; 26 (1): 1-3
DOI: 10.26355/eurrev_202201_27739

Parosmia after COVID-19: olfactory training, neuroinflammation and distortions of smell

A. Di Stadio, L. D’Ascanio, I. La Mantia, M. Ralli, M.J. Brenner
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 8019-8022
DOI: 10.26355/eurrev_202112_27653

Omicron (B.1.1.529) – variant of concern – molecular profile and epidemiology: a mini review

S. Kannan, P. Shaik Syed Ali, A. Sheeza
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 8012-8018
DOI: 10.26355/eurrev_202112_27652

Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics

S.A. Meo, A.S. Meo, F.F. Al-Jassir, D.C. Klonoff
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 8004-8011
DOI: 10.26355/eurrev_202112_27651

Photodynamic therapy procedures in coronavirus (COVID-19) outbreak: perception of health risks among clinical dental faculty and dental students

A. Alsaffan
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 7997-8003
DOI: 10.26355/eurrev_202112_27650

Scanning electron microscopy of lung disease due to COVID-19 – a case report and a review of the literature

T. Congiu, R. Demontis, F. Cau, M. Piras, D. Fanni, C. Gerosa, C. Botta, A. Scano, A. Chighine, E. Faedda, R. Cau, P. Van Eyken, F. Marongiu, D. Barcellona, L. Saba, G. Orrù, F. Coghe, J.S. Suri, G. Faa, E. d’Aloja
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 7985-7996
DOI: 10.26355/eurrev_202112_27649

Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare

N. Ughi, F. Del Gaudio, A. Dicuonzo, M. Orso, G. Micheloni, M. Puoti, A. Pani, F. Scaglione, L. Zoppini, C. Rossetti, O.M. Epis, G. Bellavia, S. Giroldi, M. Moreno, M. Bosio
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 7976-7984
DOI: 10.26355/eurrev_202112_27648

Convalescent plasma as a potential management option in COVID-19: a critical review of randomized controlled registered trials

S.A. Azer
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 7971-7975
DOI: 10.26355/eurrev_202112_27647

COVID-19 associated pulmonary embolism with D-dimer values within the referent range: a case report and review of the literature

J. Javorac, D. Živanović, S. Stojkov, J.Đ. Miličić, E. Fradelos, N. Savić
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 7964-7970
DOI: 10.26355/eurrev_202112_27646

Developing mental health nursing strategies for the inbound quarantined population in China during the COVID-19 global pandemic

P. Zhao, X.L. Ma
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 7622-7625
DOI: 10.26355/eurrev_202112_27608

Editorial – Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow

B. Rinaldi, V. Rosato, R. Galiero, E. Vetrano, M. Fasano, L. Rinaldi
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (24): 7619-7621
DOI: 10.26355/eurrev_202112_27607

COVID-19, food supplements and pediatricians. Knowledge of the products and their use: a national survey

A. Della Volpe, L. D’Ascanio, A. Di Stadio
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7607-7615
DOI: 10.26355/eurrev_202112_27459

The preoperative evaluation of post-COVID-19 patients scheduled for elective surgery – What is important not to miss!

M. Tunescu, R. Christodorescu, A. Sharma, C.R. Barsac, A.F. Rogobete, D.C. Crisan, S.E. Popovici, N.R. Kundnani, D. Sandesc, O. Bedreag
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7598-7606
DOI: 10.26355/eurrev_202112_27458

Immunohistochemical analysis of CD68, CD4, CD8 and CD20 expression in cervical dysplasia and its relationship with HR-HPV infection

J. Raonic, M. Lopicic, L. Vuckovic, J. Vucinic
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7585-7597
DOI: 10.26355/eurrev_202112_27457

Associations between severe pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients

C. Yu, X.-Y. Hu, C. Zou, F.-F. Yu, B. Liu, Y. Li, Y. Liu, L.-J. Song, L. Tan, Q. Li, Y.-C. Hu, H.-Y. He, M.-Y. Chen, Z. Zou
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7565-7584
DOI: 10.26355/eurrev_202112_27456

Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine/hydroxychloroquine) on COVID-19 (SARS-CoV-2) infection

G.E.-S. Batiha, H.M. Shaheen, H.M. Al-Kuraishy, J.O. Teibo, O.A. Akinfe, A.I. Al-Garbee, T.K.A. Teibo, S.M. Kabrah
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7553-7564
DOI: 10.26355/eurrev_202112_27455

Effect of ambient air pollutants PM2.5 and PM10 on COVID-19 incidence and mortality: observational study

S.A. Meo, T. Al-Khlaiwi, C.H. Ullah
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7543-7552
DOI: 10.26355/eurrev_202112_27454

Effects of direct-acting antiviral therapy for patients with advanced hepatocellular carcinoma and concomitant hepatitis C—A population-based cohort study

H.-Y. Tsai, H.-P. Chang, C.-J. Chen, W.-L. Hsu, L.-Y. Huang, P.-C. Lee
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7526-7542
DOI: 10.26355/eurrev_202112_27453

SARS-CoV-2 associated pathogenesis, immune dysfunction and involvement of host factors: a comprehensive review

W. Waqar, S. Ismail, Z. Jamil, A. Al-Shehhi, M. Imran, H.F. Hetta, K. Muhammad, Y. Waheed
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7516-7525
DOI: 10.26355/eurrev_202112_27452

Jordanians’ willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters

A.M. Rababa’h, N.N. Abedalqader, M. Ababneh
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (22): 7185-7191
DOI: 10.26355/eurrev_202111_27271

Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia

S.A. Meo, F. Fahad Al-Jassir, S. Al-Qahtani, R. Albarrak, A.M. Usmani, D.C. Klonoff
Free PDF Download